BriefTea
Every story in sixty words
Get the free app no ads · no paywallExplained in plain English
Yes, as seen with Pelacarsen. While Lp(a) is a risk factor, heart disease is multi-faceted. Other factors like inflammation, blood pressure, and other types of cholesterol also contribute. Lowering one specific particle, even significantly, might not be enough to prevent events if other risks remain unaddressed.
Stories that explain this
Novartis drug that cut cholesterol particle 78% failed to stop heart attacksRelated explainers
Why is Lp(a) so hard to treat? What is a 'neutral' trial result? Why stop drug development now? Why do apps fail? Why do companies fail? Why current guidelines fail Why do goals often fail? What happens if 999 fails?The full catalogue
Browse every card filed under L →We would like to count visits and see which links bring readers here. That means storing a random ID in your browser. No cookies, no ads, no profile. How it works.